Literature DB >> 7009412

A haemolytically non-active C4 gene product.

P Teisberg, B Olaisen, R Nordhagen, E Thorsby, T Geddedahl.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 7009412     DOI： 10.1016/s0171-2985(80)80046-5

Source DB:  PubMed          Journal:  Immunobiology        ISSN： 0171-2985            Impact factor:   3.144


× No keyword cloud information.
  9 in total

1.  A product of the C4B locus lacking hemolytic activity.

Authors:  K Suzuki; G J O'Neill; H Matsumoto
Journal:  Hum Genet       Date:  1986-06       Impact factor: 4.132

2.  Genetics of human C4 polymorphism: detection and segregation of rare and duplicated haplotypes.

Authors:  C Rittner; C M Giles; M H Roos; P Démant; E Mollenhauer
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

Review 3.  On the significance of C2, C4, and factor B polymorphisms in disease.

Authors:  C Rittner; J Bertrams
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

4.  HLA-linked complement polymorphisms (C2, BF) in psoriasis.

Authors:  G Dewald; C E Lange; E Schmeel; H W Kreysel
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

5.  Unequal expression of complement C4A and C4B genes in rheumatoid synovial cells, human monocytoid and hepatoma-derived cell lines.

Authors:  A Falus; J Kramer; E Walcz; Z Varga; J Setalo; K Jobst; T Lakatos; K Merétey
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

6.  Human C4 polymorphism: pedigree analysis of qualitative, quantitative, and functional parameters as a basis for phenotype interpretations.

Authors:  G Mauff; K Bender; C M Giles; S Goldmann; W Opferkuch; B Wachauf
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

7.  The complement component C4 in black Americans with type 1 (insulin-dependent) diabetes mellitus.

Authors:  B Budowle; J M Roseman; R C Go; B O Barger; R T Acton
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

8.  The purification and properties of some less common allotypes of the fourth component of human complement.

Authors:  A W Dodds; S K Law; R R Porter
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

9.  The origin of the very variable haemolytic activities of the common human complement component C4 allotypes including C4-A6.

Authors:  A W Dodds; S K Law; R R Porter
Journal:  EMBO J       Date:  1985-09       Impact factor: 11.598
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.